Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 6811
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152773(4-(3-Morpholinopropoxy)-N-(3-chloro-4-fluorophenyl...)
Affinity DataIC50: 10.4nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM5447(ZD1839 | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[...)
Affinity DataIC50: 12.1nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152779(4-(3-(Piperidin-1-yl)propoxy)-N-(3-chloro-4-fluoro...)
Affinity DataIC50: 15.4nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152777(4-(3-(Piperidin-1-yl)propoxy)-N-(m-tolyl)-2-hydrox...)
Affinity DataIC50: 22.4nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152780(4-(3-(Piperidin-1-yl)propoxy)-N-(2-chloro-4-nitrop...)
Affinity DataIC50: 23nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152772(4-(3-Morpholinopropoxy)-N-(3-(trifluoromethyl)phen...)
Affinity DataIC50: 34.6nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152778(4-(3-(Piperidin-1-yl)propoxy)-N-(3-(trifluoromethy...)
Affinity DataIC50: 35.2nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152775(4-(3-(Piperidin-1-yl)propoxy)-N-(3-bromophenyl)-2-...)
Affinity DataIC50: 45.7nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152776(4-(3-(Piperidin-1-yl)propoxy)-N-(3-chlorophenyl)-2...)
Affinity DataIC50: 63.9nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152774(4-(3-Morpholinopropoxy)-N-(2-chloro-4-nitrophenyl)...)
Affinity DataIC50: 84.8nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152769(4-(3-morpholinopropoxy)-N-(3-bromophenyl)-2-hydrox...)
Affinity DataIC50: 85.8nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152771(4-(3-Morpholinopropoxy)-N-(m-tolyl)-2-hydroxybenza...)
Affinity DataIC50: 142nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed
TargetEpidermal growth factor receptor [1-973](Human)
Anhui University of Chinese Medicine

LigandPNGBDBM152770(4-(3-Morpholinopropoxy)-N-(3-chlorophenyl)-2-hydro...)
Affinity DataIC50: 196nMT: 2°CAssay Description:The experiments were performed according to the instructions of the manufacturer. The EGFR TK activity was performed using Kinase-Glo Plus luminescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2015
Entry Details Article
PubMed